Related Experiment Video

Updated: May 10, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Cardiac valve calcification: an immutable pathologic finding in chronic kidney disease?

Antonio Bellasi, Andrea Galassi, Sergio Papagni

    Journal of Nephrology
    |June 29, 2013
    PubMed

    Insights

    Cardiac valve calcification (CVC) is a clinical issue, especially in older adults and those with kidney impairment. A study suggests a low-phosphate diet and sevelamer may reduce CVC, highlighting mineral metabolism

    Area of Science:

    • Nephrology
    • Cardiology
    • Mineral Metabolism

    Background:

    • Cardiac valve calcification (CVC) affects 2%-10% of adults over 75, and is 5-10x more common in impaired kidney function.
    • Mineral metabolism abnormalities, beyond traditional cardiovascular risk factors, are implicated in CVC pathogenesis.
    • Limited research exists on the impact of manipulating mineral metabolism on CVC progression.

    Discussion:

    • A recent study indicates that combining a low-phosphate diet with sevelamer may decrease CVC.
    • The observational nature and lack of a control group limit the generalizability of these findings.
    • These results contribute to the ongoing discussion regarding chronic kidney disease mineral bone metabolism (CKD-MBD) in vascular disease.

    Key Insights:

    • Mineral metabolism plays a role in cardiac valve calcification (CVC) pathogenesis.
    • Dietary phosphate restriction and sevelamer show potential in reducing CVC.
    • Controlling mineral metabolism is crucial for patients with chronic kidney disease (CKD).

    Outlook:

    • Further controlled studies are needed to confirm the efficacy of mineral metabolism manipulation in CVC.
    • Investigating the CKD-MBD pathway's role in vascular calcification remains a key research area.
    • Optimizing mineral metabolism management in CKD patients may mitigate cardiovascular risks.

    More Related Videos

    A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro11:30

    A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

    Published on: June 2, 2022

    Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro05:47

    Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

    Published on: May 10, 2021

    Related Concept Videos

    Chronic Kidney Disease I: Introduction01:25

    Chronic Kidney Disease I: Introduction

    Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
    Chronic Kidney Disease II: Clinical Manifestations01:24

    Chronic Kidney Disease II: Clinical Manifestations

    Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
    Chronic Kidney Disease IV: Nursing Management01:18

    Chronic Kidney Disease IV: Nursing Management

    Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
    Chronic Kidney Disease III: Interprofessional Care01:28

    Chronic Kidney Disease III: Interprofessional Care

    Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
    Urinary Tract Calculi I: Introduction01:28

    Urinary Tract Calculi I: Introduction

    Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

    Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...